> That's not too surprising since the Cass review just looks at transgender care, and not anything else. Which is a bizarre choice on its face, given that chil

> That's not too surprising since the Cass review just looks at transgender care, and not anything else. Which is a bizarre choice on its face, given that children with precocious puberty tend to be on these drugs for longer than those with gender dysphoria. > If people had been actually researching this instead of obsessing over JK Rowling and generally being an asshole on twitter then everyone would be better off by now, trans kids most of all. I believe that transgender people and their supporters are rightfully worried that this is the harbinger to significantly restricting or altogether banning gender-affirming care across the board, even for consenting and informed adults. If I thought I would lose access to medication that allowed me to not only function, but live a happier and more fulfilling life, as is the case in many US states, I'd be a bit cross as well. Then again, I also don't feel like laying this problem at Twitter users' feet is very productive, considering how much of a trash fire the site is in its sum total no matter what conversation you're having.